A randomized, pilot trial of etanercept in dermatomyositis.
about
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositisIdiopathic Inflammatory Myopathies: Clinical Approach and ManagementTreatment of inflammatory myopathy: emerging therapies and therapeutic targetsScanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesDevelopments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesIdiopathic inflammatory myopathiesImmunotherapies for Immune-Mediated Myopathies: A Current PerspectiveBiologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Idiopathic inflammatory myopathies.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Cutaneous dermatomyositis in the era of biologicals.An overview of polymyositis and dermatomyositis.Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.Inflammatory myopathies: One-center experience.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment.Management of cutaneous dermatomyositis.Targeted immunotherapy trials for idiopathic inflammatory myopathies.Monoclonal antibodies in neuroinflammatory diseases.Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.Diagnosis, pathogenesis and treatment of myositis: recent advances.Abatacept as a successful therapy for myositis—a case-based review.Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Idiopathic inflammatory myopathies-a review.The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Current pharmacological treatment of idiopathic inflammatory myopathies.Update on the pharmacological treatment of adult myositis.2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatri2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric RheumatologyIntegrated classification of inflammatory myopathies.Pharmacological management of dermatomyositis.[Dermatomyositis-update].Novel approaches in the treatment of myositis and myopathies.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Fetal and neonatal involvement in maternal rheumatologic disease.
P2860
Q24201580-65BFF849-EB0D-4B0B-97CB-0613E9083276Q26744705-BDEB9C90-BDD2-449D-B9BF-FA4E748434E7Q26796546-1372EF71-B358-4216-A50E-B08040D65022Q26798209-07CE0C18-EF9A-4905-9A58-E8BEB3F91E09Q26863125-44D735B3-4504-46A5-840F-4CA67D8BDEACQ27025125-908B764E-83EB-4AA8-B33C-7E2A5BABB1A2Q30699742-088D5EA9-D57F-4446-B001-E8399D25CFAEQ33795594-D711F09E-6DD7-44E5-BF5A-189954CD94B1Q33924451-52167CBB-90C6-45C4-A0DE-5BFD0A7B14CDQ34349952-AB692E64-7A16-427D-9ED7-039BD6B146A9Q34501531-550B4ED0-F94D-4777-89CB-00C5366DE49AQ34667765-0F13352B-D05A-4A05-9069-73CACDB9166DQ35900966-1A3574E1-A8CC-40A5-9FF8-2EBC88A2F2B0Q36278027-6821FC6F-5E70-44E1-AAE7-165E8B2F73FEQ37095730-4ED13490-4D27-4E61-8C53-E39EBD3BA804Q37296359-F74D867E-195C-4193-9930-A687A27629F9Q37368405-F40E365F-F583-40C2-8D4F-31C55E0153BCQ37704799-2746B9FA-52AC-4B45-A606-723174FEA270Q37988393-D71CABE0-24F5-42E6-B5D9-AAE06464DF7FQ38022271-740EF7BE-0E25-4CDB-AC69-9BCA04BA3EA1Q38023207-C0D06C44-64C8-4778-90CD-CC96DE263392Q38092121-E3D59FDD-9CDC-437A-BBDE-6EB94E7A5792Q38130904-4F79A980-35F2-475A-8581-BF188B37CA4EQ38131849-AB592E93-875D-4417-844B-58ABB609685DQ38184953-6610C57C-88DA-4423-931E-5CE5AA467CE1Q38244567-0A40525D-9A76-4F77-B011-1805393BD76AQ38355216-E79442CA-4C1A-4C54-AE89-E2119C2D9DEEQ38572045-8220555A-0B0E-4511-9327-AEEF91D27A0EQ38589301-46C0908B-0EBC-4F5C-B099-D79C6BB20BAEQ38597575-2109ED4C-EA16-492A-924D-6CB39415F3F7Q38680762-09BB4A68-C45B-467E-A189-1A9B94E22914Q38813275-034D86B6-6ED8-4B92-B67F-EDD9BAE84CBBQ38849144-D7D72EE1-6BB8-4686-9C9C-E19461ACE1C9Q38849148-36E8C13A-9E5F-4C61-B759-01C8163D6B1DQ39027323-96D5947A-8754-4A13-A4CA-2DF899D1F9F6Q39425296-A867E602-AA55-4A6E-B779-A185EC6B74A7Q41085880-A1D85FD8-54ED-49BA-ADE1-0E44DBF939C2Q41977818-6F2FAAAE-A12C-4A64-AFE7-C53D7A28EDA1Q42365042-CF23CF1D-75CB-4EFD-B6E6-1F16B6C14E96Q46304168-DFEE2557-D7AC-4DA4-A827-A26D4F206F41
P2860
A randomized, pilot trial of etanercept in dermatomyositis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A randomized, pilot trial of etanercept in dermatomyositis.
@ast
A randomized, pilot trial of etanercept in dermatomyositis.
@en
type
label
A randomized, pilot trial of etanercept in dermatomyositis.
@ast
A randomized, pilot trial of etanercept in dermatomyositis.
@en
prefLabel
A randomized, pilot trial of etanercept in dermatomyositis.
@ast
A randomized, pilot trial of etanercept in dermatomyositis.
@en
P2860
P356
P1433
P1476
A randomized, pilot trial of etanercept in dermatomyositis.
@en
P2093
Muscle Study Group
P2860
P304
P356
10.1002/ANA.22477
P577
2011-06-17T00:00:00Z